Advanced in Peripheral T-Cell Lymphoma

Karin Bilger

Chu
Strasbourg, FR 
Advanced in Peripheral T-Cell Lymphoma
Chu
Strasbourg, FR 
OverviewLocationsClinical Research

Overview

Karin Bilger practices in Strasbourg, France. Ms. Bilger is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Leukemia, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Peripheral T-Cell Lymphoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Peripheral T-Cell Lymphoma.

Gender
Female

Locations

CHU
Strasbourg, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer
Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer
Enrollment Status: Completed
Publish Date: February 23, 2021
Intervention Type: Drug
Study Phase: Phase 2

35 Total Publications

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).
Journal: American journal of hematology
Published: January 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bilger's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile